FibroBiologics reported total assets of $7.93M and total liabilities of $3.29M for the quarter ended Jun 2026, down 43.0% year over year. This balance sheet covers 15 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.05M | 0.12M | 0.16M | 0.20M | 0.26M | 0.32M | 0.38M | 0.45M | 0.51M | 0.58M | |||||
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash & EquivalentsCash & Equiv. | 2.27M | 9.16M | 8.16M | 5.97M | 7.83M | 14.00M | 8.67M | 8.85M | 4.90M | 4.90M | 1.50M | 3.52M | |||
| Receivables - NetNet Receivables | 0.30M | ||||||||||||||
| Receivables | 0.30M | ||||||||||||||
| Prepaid Assets | 0.03M | 0.04M | 0.75M | 0.52M | 0.35M | 0.23M | 0.64M | 1.33M | 0.37M | 1.46M | 1.02M | 0.53M | |||
| Current Assets | 2.62M | 9.21M | 8.92M | 6.51M | 8.20M | 14.23M | 9.33M | 10.18M | 5.24M | 6.35M | 2.90M | 5.85M | |||
| Non-Current Assets | |||||||||||||||
| Property, Plant & Equipment (Net) | 0.80M | 0.77M | 0.80M | 0.77M | 0.82M | 0.81M | 0.97M | 0.91M | 0.84M | 0.78M | 0.71M | ||||
| Other Non-Current Assets | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | ||||||||||
| Non-Current Assets | 2.20M | 2.61M | 2.48M | 2.40M | 2.27M | 2.22M | 2.10M | 3.73M | 3.50M | 3.27M | 3.03M | 2.08M | |||
| Assets | 4.82M | 11.82M | 11.40M | 8.91M | 10.47M | 16.45M | 11.43M | 13.91M | 8.74M | 9.62M | 5.94M | 7.93M | |||
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payables | 0.76M | 1.44M | 0.81M | 1.21M | 1.18M | 2.70M | 1.42M | 1.80M | 1.07M | 0.94M | 0.85M | 1.82M | |||
| Notes Payables | 5.45M | 0.46M | 0.29M | 0.12M | 10.00M | 5.84M | 8.07M | 9.70M | 11.60M | ||||||
| Payables | 6.21M | 1.44M | 1.27M | 1.50M | 1.29M | 12.70M | 7.26M | 9.87M | 10.77M | 12.54M | 0.85M | 1.82M | |||
| Short term Debt | 0.25M | 0.12M | |||||||||||||
| Current Leases | 0.33M | 0.36M | 0.37M | 0.38M | 0.39M | 0.40M | 0.41M | 0.63M | 0.64M | 0.71M | 0.72M | 0.26M | |||
| Current Deferred Revenue | 1.50M | 0.24M | |||||||||||||
| Total Current Liabilities | 7.07M | 9.18M | 13.98M | 10.13M | 6.68M | 12.73M | 8.21M | 10.96M | 6.72M | 1.76M | 1.83M | 2.21M | |||
| Non-Current Liabilities | |||||||||||||||
| Convertible Debt | 5.60M | ||||||||||||||
| Operating Leases | 1.75M | 1.39M | 1.65M | 1.55M | 1.05M | 0.98M | 1.28M | 2.08M | 1.90M | 1.70M | 1.51M | 1.08M | |||
| Other Non-Current Liabilities | 2.57M | 0.46M | 2.57M | 0.00M | 4.81M | 2.89M | |||||||||
| Total Non-Current Liabilities | 6.25M | -1.10M | -13.93M | 10.57M | 15.26M | 6.49M | 4.84M | 13.71M | |||||||
| Total Liabilities | 8.82M | -0.64M | -11.35M | -10.54M | 10.57M | 15.26M | 11.30M | 7.73M | 13.71M | 9.08M | 13.05M | 8.62M | 3.46M | 3.34M | 3.29M |
| Shareholder's Equity | |||||||||||||||
| Total Debt | 5.45M | 0.46M | 0.29M | 0.12M | 10.00M | 5.84M | 8.07M | 9.70M | 11.60M | 0.25M | 0.12M | ||||
| Common Equity | 62.50M | 0.64M | 11.35M | 10.54M | 1.25M | 100.00M | -2.39M | 2.74M | 2.73M | 2.35M | 0.86M | 0.12M | 6.16M | 2.60M | 4.64M |
| Liabilities and Shareholders Equity | 4.82M | 11.82M | 11.40M | 8.91M | 10.47M | 16.45M | 11.43M | 13.91M | 8.74M | 9.62M | 5.94M | 7.93M | |||
| Retained Earnings | -7.87M | 25.61M | -32.82M | -31.92M | 35.16M | 38.25M | 42.83M | 46.00M | 51.05M | 60.32M | 61.76M | 67.92M | |||
| Preferred Shares | 2.50M |